BARD1 Competitors and Similar CompaniesClear all
BARD1's competitors and similar companies include Cardiff Oncology and Cellis.
 BARD1 BARD1 Life Sciences is a company focused on developing and commercializing non-invasive diagnostic tests for early detection of cancer. |  Cellis Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology. | ||
Founding Date | Founding Date 2016 | Founding Date 1999 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Notting Hill, AU HQ | Locations San Diego, US HQ | Locations Zürich, CH HQ Warsaw, PL |
Employees | Employees 5 | Employees 14 | Employees 23 |
Valuation ($) | Valuation ($) 62.9 m | Valuation ($) 145.2 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $547k (FY, 2025) | Revenue (est.) $593k (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($6.9m) (FY, 2025) | Net income ($45.9m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Cellis
HQ
Zürich, CH
Employees
23
Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology.
View company